Scitech Development, Inc.
Clinical trials sponsored by Scitech Development, Inc., explained in plain language.
-
New hope for tough lung cancer: experimental drug ST-001 enters human testing
Disease control Recruiting nowThis early-phase trial tests an experimental drug called ST-001 (a form of fenretinide) in people with small cell lung cancer that has returned or stopped responding to standard treatments. The main goals are to find the safest dose and to watch for any side effects. About 44 par…
Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for tough lymphoma: experimental drug ST-001 enters human testing
Disease control Recruiting nowThis early-phase trial tests a new drug called ST-001 in people with T-cell non-Hodgkin lymphoma that has returned or not responded to prior treatments. The main goals are to find the safest dose and to watch for side effects. About 46 participants will receive the drug through a…
Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC